Two recent comments from Calumet Specialty Products (CLMT) management provide further positive investor insight into the company's future financial health. The two news releases included these actions: reducing G&A expenses by $20 million/year and a capacity increase of 7K capacity at Shreveport. On the surface, the changes seem trivial. In our view, it isn't. Calumet's direction toward a valued and very profitable specialty company means that its combined specialty and Shreveport refining business married together must pay bills and generate lucrative levels of profit (free cash). In our view, the level of free cash is